Angiodynamics (ANGO) EBITDA Margin Growth (5y) (2015 - 2026)
Powered by 
Analysis
Angiodynamics (ANGO) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.94 Bn | 175.34 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.83 Bn | 122.62 Bn | 1.96 Bn |
| 3 | Medtronic | 116.96 Bn | 108.14 Bn | 6.34 Bn |
| 4 | Stryker | 104.44 Bn | 100.97 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.87 Bn | 63.33 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.91 Bn | 45.65 Bn | 1.35 Bn |
| 7 | Alcon | 33.06 Bn | 31.60 Bn | 1.68 Bn |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn |
| 9 | Steris | 20.68 Bn | 20.20 Bn | 684.20 Mn |
| 10 | Angiodynamics | 626.63 Mn | 572.76 Mn | 46.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 1,632.00 |
| Feb 28, 2026 | -1,126.00 |
| Nov 30, 2025 | -107.00 |
| Aug 31, 2025 | -678.00 |
| May 31, 2025 | 26,126.00 |
| Feb 28, 2025 | -492.00 |
| Nov 30, 2024 | -1,034.00 |
| Aug 31, 2024 | -1,815.00 |
| May 31, 2024 | -2,448.00 |
| Feb 29, 2024 | -26,028.00 |
| Nov 30, 2023 | -1,298.00 |
| Aug 31, 2023 | 5,411.00 |
| May 31, 2023 | 778.00 |
| Feb 28, 2023 | -1,866.00 |
| Nov 30, 2022 | -1,118.00 |
| Aug 31, 2022 | -1,653.00 |
| May 31, 2022 | 3,346.00 |
| Feb 28, 2022 | -1,316.00 |
| Nov 30, 2021 | -2,860.00 |
| Aug 31, 2021 | -1,458.00 |